Antibodies
Israeli startup to use AI to transform antibody discovery, design
"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.
Researchers find new way to make animal antibodies safe for humans
Flu viruses may be combated with new antibody, study finds
Sleeping less than six hours will decrease vaccine effectiveness - study
COVID-19: Loss of taste, smell? It may actually be a good thing - study
Olfactory loss typically appears early in the onset of COVID-19 and at times could be the sole indicator that an individual is actually sick, as 20% of patients may have no other symptoms.
Omicron subvariants getting better at evading antibodies
Scientists have been increasingly focusing on the BA.2.75.2, BF.7 (also known as BA.5.2.1.7) and BQ.1.1 variants in recent weeks.
COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study
Breakthrough infections of COVID-19 Omicron BA.2 in people who have received the Pfizer/BioNTech vaccine have more antibodies against the dominant BA.4/BA.5 descendants.
New HIV vaccine can produce strong antibodies - study
The study notes the obstacle to creating a vaccine that can induce strong antibodies that can neutralize HIV strains.
Scientists find COVID-19 antibodies that can make boosters unnecessary
Researchers at Tel Aviv University found two antibodies that neutralize all known strains of COVID-19 with up to 95% efficiency.
Deauthorized COVID-19 treatments still administered in 2022 - study
Researchers discovered that in early 2022, hospitals administered 158,000 doses of unauthorized monoclonal antibody treatments.
This antibody may protect against COVID-19 and all its variants - study
The antibody in question was easily induced in rhesus macaque monkeys and provided broad protection against not just COVID-19 and variants but other SARS viruses.
COVID-19: Blood cancer patients gain antibodies from vaccine booster - study
Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.
New rapid test measures immunity to COVID-19
The study, conducted at Mount Sinai, is one of the first to successfully measure T cell responses, which may be able to ensure protection after antibodies are gone.
Israeli researchers find a new, natural weapon for fighting cancer
Natural antibodies found in tumors could point the way toward improved immunotherapy, according to a new Weizmann Institute study, a potential cancer breakthrough.
Children infected by COVID continue to have antibodies - How protected are they?
Study shows that children infected with COVID-19 continue to have antibodies at least six months afterwards, but protection against Omicron still unclear.